Table 1 Patient baseline demographics by head pain outcome group at 2 h post-dose
Parameter | Pain freedom (N = 913) | Improved to mild pain (N = 864) | Continued moderate/severe pain (N = 1052) |
|---|---|---|---|
Age, mean (SD) | 41.9 (12.9) | 41.8 (12.1) | 42.6 (11.8) |
Female, n (%) | 780 (85.4) | 745 (86.2) | 885 (84.1) |
White, n (%) | 711 (78.0) | 734 (85.0) | 908 (86.3) |
Body mass index, mean (SD) | 30.3 (7.8) | 30.4 (10.6) | 29.9 (7.8) |
Family history of coronary artery disease, n (%) | 277 (30.3) | 251 (29.1) | 346 (32.9) |
Duration of migraine history years, mean (SD) | 17.2 (12.6) | 19.0 (12.8) | 20.0 (12.8) |
Average migraine attacks/month in past 3 months, mean (SD) | 5.1 (1.6) | 5.2 (1.9) | 5.4 (2.1) |
Use of migraine preventive medicationa, n (%) | 155 (17.0) | 186 (21.5) | 252 (24.0) |